Acquisition History The Craneware Group acquired Sentry in 2021, indicating a recent consolidation of pharmacy and healthcare software assets. This suggests potential cross-sell opportunities to customers already in Craneware’s ecosystem and the need to navigate integration and data-sharing enhancements for unified solutions.

Cybersecurity Posture Multiple 2026 cybersecurity incidents involving Craneware highlight the importance of robust security offerings. This creates an opportunity to present advanced data protection, breach detection, and incident response services as complementary protections for Sentry’s client base and data-heavy workflows.

Data Accessibility Notable exposure of large datasets through prior acquisitions and subsequent breaches indicates a demand for secure data governance, MDM, and compliant analytics. Position data integration, lineage, and secure cloud analytics as value-adds for customers handling sensitive patient and pharmacy data.

Analytics Maturity Current tech stack includes Power BI and Oracle Cloud, suggesting existing emphasis on analytics and cloud-based workflows. Opportunity to offer advanced BI accelerators, reporting templates, and scalable analytics solutions to deepen customer reliance on data-driven decision making.

Mid-market Focus Company size of 51-200 employees with revenue in the $100M–$250M range points to mid-market priorities such as cost-effective integration, rapid deployment, and strong customer support. Tailor scalable SaaS offerings, rapid-onset deployments, and favorable terms for expanding footprints in similar mid-market healthcare software clients.